ELISE BUCKLEY: Open Payments
NPI 1023602877 · CLINTON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,294 in 122 payments from 22 companies in 2025. Trend: 2023 $2,228 · 2024 $2,817 · 2025 $2,294
Food & beverage: $2,209Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $311 |
| Novartis Pharmaceuticals Corporation | 26 | $274 |
| Galderma Laboratories, L.P. | 11 | $261 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $227 |
| UCB, Inc. | 9 | $173 |
| LEO Pharma Inc. | 9 | $167 |
| PFIZER INC. | 4 | $166 |
| Janssen Biotech, Inc. | 4 | $99 |
| Incyte Corporation | 5 | $95 |
| Mallinckrodt Hospital Products Inc. | 3 | $79 |
Products named: COSENTYX, NEMLUVIO, SKYRIZI, Bimzelx, CIBINQO, RINVOQ, ANZUPGO, DUPIXENT.
Industry payments across MS — which companies pay providers there.
